218 related articles for article (PubMed ID: 396404)
1. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
[No Abstract] [Full Text] [Related]
2. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
3. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients.
Mimran A; Shaldon S; Barjon P; Mion C
Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368
[TBL] [Abstract][Full Text] [Related]
4. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 2) change of renin-angiotensin-aldosterone system during hemodialysis (author's transl)].
Fukuchi S; Nakajima K
Nihon Jinzo Gakkai Shi; 1977 Oct; 19(10):809-14. PubMed ID: 604580
[No Abstract] [Full Text] [Related]
5. [Saralasin for renovascular or essential hypertension (author's transl)].
Arlart I; Rosenthal J
Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
[No Abstract] [Full Text] [Related]
6. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of effects of two angiotensin II antagonists on blood pressure, heart rate, plasma renin activity, and plasma aldosterone concentration in the same hypertensive patients].
Higuma K; Fujishima S; Shionoiri H; Tochikubo O; Uneda S; Fujiki Y; Kaneko Y
Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):425-35. PubMed ID: 6381833
[No Abstract] [Full Text] [Related]
8. Effect of saralasin on plasma aldosterone in hypertensive man.
Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
[No Abstract] [Full Text] [Related]
9. [Effect of the angiotensin antagonist saralasin on blood pressure and hemodynamics in patients with terminal renal insufficiency].
Tuma J; Beckerhoff R; Záruba K; Furrer J; Vetter W
Schweiz Med Wochenschr; 1977 May; 107(20):704-9. PubMed ID: 867013
[TBL] [Abstract][Full Text] [Related]
10. Use of saralasin in end-stage renal disease.
Fadem SZ; Lifschitz MD
Kidney Int Suppl; 1979 Mar; (9):S93-100. PubMed ID: 289869
[No Abstract] [Full Text] [Related]
11. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
Vierhapper H; Waldhäusl W
Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
[TBL] [Abstract][Full Text] [Related]
12. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
[TBL] [Abstract][Full Text] [Related]
13. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
[TBL] [Abstract][Full Text] [Related]
14. Effect of the angiotensin II antagonist saralasin on plasma aldosterone concentration and on blood pressure before and during sodium depletion in normal subjects.
Agabiti-Rosei E; Brown JJ; Brown WC; Fraser R; Trust PM; Lever AF; Morton JJ; Robertson JI
Clin Endocrinol (Oxf); 1979 Mar; 10(3):227-34. PubMed ID: 455738
[TBL] [Abstract][Full Text] [Related]
15. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
[TBL] [Abstract][Full Text] [Related]
16. [Saralasin in subjects with low renin arterial hypertension].
Frisina N; Buemi M; Lasco A; Macrí I; Ciraolo O; Nicita Mauro V; Costa G
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1367-73. PubMed ID: 7004464
[TBL] [Abstract][Full Text] [Related]
17. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
[No Abstract] [Full Text] [Related]
19. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 3) Change of the renin-angiotensin-aldosterone system after bilateral nephrectomy and kidney transplantation in chronic renal failure (author's transl)].
Fukuchi S; Nakajima K; Sekino H; Ishizaki M
Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):305-13. PubMed ID: 353341
[No Abstract] [Full Text] [Related]
20. [Effects of saralasin on 20 hypertensive patients (author's transl)].
Plaza de los Reyes M; Passalacqua W; Plaza de los Reyes X; Pla C; Campino C
Rev Med Chil; 1980 Feb; 108(2):115-20. PubMed ID: 7017869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
